期刊名称：ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Environmental and Molecular Mutagenesis publishes original research articles on environmental mutagenesis. It will publish manuscripts in the six general areas of mechanisms of mutagenesis; genomics; DNA damage; replication, recombination, and repair; public health; and DNA technology. Subsumed under these six general areas are subject matters that are appropriate for inclusion in EMM.
Mechanisms of Mutagenesis
spontaneous and induced mutation in indigenous and transgene systems
genomic instability
mutation rates
the consequence of mutation on fitness and evolution of organisms
Genomics
molecular epidemiology
genetic susceptibility
gene expression
biomarkers
small genomes and comparative genomics
DNA Damage
Indentification, detection, characterization, and quantification of DNA damage
metabolism of chemicals into DNA-damaging agents
Replication, Recombination, and Repair
genetic and biochemical mechanisms
genetic and infectious disease
insertions, deletions, rearrangements, aneuploidy
Public Health
Issues impacting basic human health such as cancer, genetic disease, aging, or acute and chronic disease
methodologies that will lead to better methods to determine risk and help to define regulatory policy
DNA Technology
DNA microarrays, differential dispaly, and mutation detection analysis
novel sequencing strategies
bioimaging techniques
bioinformatics and functional genomics
The study of environmental mutagenesis is a multidisciplinary activity. The journal is intended for investigators in such fields as genetics, microbiology, biochemistry, basic cancer research, radiation biology, and toxicology. It should as well be of interest to a wide audience of scientists in other areas of biology, chemistry, and medicine that are engaged in public health research or in formulating public health policy.
Instructions to Authors
Manuscripts and all editorial correspondence should be sent by first-class mail, or air, to:
Dr. Robert H. Heflich
US FDA/National Center for Toxicological Research
3900 NCTR Rd.
Jefferson, AR 72079, USA
Telephone: (870) 543-7493; Telefax: (870) 543-7393
E-mail: RHeflich@NCTR.FDA.gov
We ask that authors take an active role in ensuring a cogent and efficient review process.
Therefore, in addition to submitting four copies of the manuscript, include a letter stating:
- briefly the major thrust of the manuscript.
- assurance that the work submitted has not been published or submitted for publication elsewhere.
- names of colleagues who have reviewed the submission.
- names, addresses, telephone and fax numbers, e-mail, and fields of expertise of three to five potential referees.
Also include:
- three copies of any manuscript by the authors that is in press that will help the reviewers in evaluating the submitted manuscript.
- written permission from scientists whose work is cited as unpublished, personal communication, or in preparation.
Manuscripts must be typed, double-spaced, on one side of white bond paper, approximately 8 1/2" by 11", with generous margins. Begin each section on a separate page. Number all pages in sequence beginning with the title page. A Guide for the Submission of Electronic Manuscripts is presented below. Submit elements in the following order:
Title Page. This should contain an informative title, a short running title, the names and affiliations of all authors, the name, address, telephone and fax numbers for the corresponding author, and an address for reprint requests.
Abstract. This should be a factual condensation of the entire work and include statements of the problem, method of study, results, and conclusion. The abstract may not exceed 250 words.
Key Words. Supply a list of three to six key words that will adequately index the subject matter of the article.
Text. Text should follow the format: Introduction, Materials and Methods, Results, Discussion, Acknowledgments, and References. All unusual abbreviations must be defined either at first mention or in a footnote. All measurements must be in metric units.
Materials and Methods. This section must be sufficiently detailed to permit other scientists to evaluate the work critically and to repeat the experiments. The source of all chemicals, all unusual supplies, the organisms used, and any unusual apparatus should be given. Strain designations and relevant information on genotypes should be clearly specified. Any deviation from published methods should be given. Authors should provide details of plant growth conditions or animal husbandry, such as food, bedding, light cycles, et cetera. Details of culture conditions and media should be provided for in vitro work. If in doubt about whether or not to include any technical detail, include it. When animals are used, authors must indicate that institutional guidelines were followed in all experiments. Experiments involving humans must indicate that appropriate safeguards have been applied and that informed consent has been obtained.
References.
Wiley's Journal Styles Are Now in EndNote
EndNote is a software product that we recommend to our journal authors to help simplify and streamline the research process. Using EndNote's bibliographic management tools, you can search bibliographic databases, build and organize your reference collection, and then instantly output your bibliography in any Wiley journal style.
Download Reference Style for this Journal: If you already use EndNote, you can download the reference style for this journal.
How to Order: To learn more about EndNote, or to purchase your own copy, click here.
Technical Support: If you need assistance using EndNote, contact endnote@isiresearchsoft.com, or visit www.endnote.com/support. In the text, cite references by the name and date system. When there are more than two authors, use the first name and et al (with period). In the final list they should be arranged alphabetically, and chronologically for more than one reference with the same authorship. Use a letter suffix if more than one author reference is for the same year. Begin each reference with the names of all authors. In the following examples, note the punctuation. Do not use all capitals. Do not underline.
Journal Articles:
Hoffmann GR, Colyer SP, Littlefield LG. 1993. Induction of micronuclei by bleomycin in G0 human lymphocytes: II. Potentiation by radioprotectors. Environ Mol Mutagen 21:136?43.
Books:
Mitelman F. 1991. Catalog of chromosome aberrations in cancer. 4th edition. New York: Wiley-Liss, Inc. 1223 p.
Chapters in Books:
Goldsworthy TL, Morgan KT, Popp JA, Butterworth BE. 1991. Guidelines for measuring chemically-induced cell proliferation in specific rodent target organs. In: Butterworth BE, Slaga TJ, editors. Chemically-induced cell proliferation: implications for risk assessment. New York: Wiley-Liss, Inc. p 253?84.
Accuracy of the references is the responsibility of the author.
Tables. Each table must have a self-explanatory title, be numbered with Roman numerals in order of appearance, and be keyed into the text, doublespaced.
Legends. A descriptive legend must accompany each illustration so that it can be understood apart from the text, and must define all abbreviations used therein, double-spaced.
Illustrations. Illustrations should be numbered in one consecutive series using arabic numerals and be referenced in the text. Name of author, figure number, and an arrow indicating orientation should be typed on a gummed label and affixed to the back of each illustration. Line drawings must be of high quality; typewritten or hand lettering is unacceptable. Either the original drawing or good quality photographic prints are acceptable. Photographs should be high contrast, glossy prints. If possible, use black and white; a charge will be made for color reproduction. Photographs may be mounted or unmounted; if mounted they may abut. Magnifications may be indicated by a micron bar or in the legend. Photographs which are to be reproduced without further reduction must be so marked and may not exceed 6 13/16" ?8 7/8" to fit the journal format. In general practice it is best to restrict the length or depth of submitted photographs to 8 1/8" to allow for legend placement. Photographs intended for single column placement should not exceed 3 5/16" in width.
Brief Communications. Short, original scientific notes may be submitted to Environmental and Molecular Mutagenesis. These should be approximately 1,000 words (two–three printed pages) and do not require abstracts. The use of abbreviations, preparation of illustrations, form for references, title page, etc., are the same as above.
Letters to the Editor. Letters should be double-spaced and will be subject to review for pertinence and content.
Commentaries. Thought-provoking items dealing with topics of interest to the readers are welcomed; maximum length should be five–six manuscript pages.
ALL MANUSCRIPTS submitted to Environmental and Molecular Mutagenesis may not have been published in any part or form, except as an abstract for a meeting. Upon acceptance of a manuscript for publication, the author(s) will be requested to sign an agreement transferring copyright to the publisher, Wiley-Liss, Inc., a division of John Wiley & Sons, Inc., 111 River Street, Hoboken, NJ 07030, who reserves copyright. No published material may be reproduced or published elsewhere without the written permission of the publisher and the author. The journal will not be responsible for the loss of manuscripts at any time. All statements in, or omissions from, published manuscripts are the responsibility of the authors who will assist the editors by reviewing proofs before publication. Reprint order forms will be sent with the proofs.
Disk Submission Instructions
Please return your final, revised manuscript on disk as well as hard copy.
The hard copy must match the disk.
The Journal strongly encourages authors to deliver the final, revised version of their accepted manuscripts (text, tables, and, if possible, illustrations) on disk. Given the near-universal use of computer word-processing for manuscript preparation, we anticipate that providing a disk will be convenient for you, and it carries the added advantages of maintaining the integrity of your keystrokes and expediting typesetting. Please return the disk submission slip below with your manuscript and labeled disk(s).
Guidelines for Electronic Submission
Text
Storage medium. 3-1/2" high-density disk in IBM MS-DOS, Windows, or Macintosh format.
Software and format. Microsoft Word 6.0 is preferred, although manuscripts prepared with any other microcomputer word processor are acceptable. Refrain from complex formatting; the Publisher will style your manuscript according to the Journal design specifications. Do not use desktop publishing software such as Aldus PageMaker or Quark XPress. If you prepared your manuscript with one of these programs, export the text to a word processing format. Please make sure your word processing program's "fast save" feature is turned off. Please do not deliver files that contain hidden text: for example, do not use your word processor's automated features to create footnotes or reference lists.
File names. Submit the text and tables of each manuscript as a single file. Name each file with your last name (up to eight letters). Text files should be given the three-letter extension that identifies the file format. Macintosh users should maintain the MS-DOS "eight dot three" file-naming convention.
Labels. Label all disks with your name, the file name, and the word processing program and version used.
Illustrations
All print reproduction requires files for full color images to be in a CMYK color space. If possible, ICC or ColorSync profiles of your output device should accompany all digital image submissions.
Storage medium. Submit as separate files from text files, on separate disks or cartridges. If feasible, full color files should be submitted on separate disks from other image files. 3-1/2" high-density disks, CD, and Iomega Zip disks can be submitted. At authors' request, cartridges and disks will be returned after publication.
Software and format. All illustration files should be in TIFF or EPS (with preview) formats. Do not submit native application formats.
Resolution. Journal quality reproduction will require greyscale and color files at resolutions yielding approximately 300 ppi. Bitmapped line art should be submitted at resolutions yielding 600-1200 ppi. These resolutions refer to the output size of the file; if you anticipate that your images will be enlarged or reduced, resolutions should be adjusted accordingly.
File names. Illustration files should be given the 2- or 3-letter extension that identifies the file format used (i.e., .tif, .eps).
Labels. Label all disks and cartridges with your name, the file names, formats, and compression schemes (if any) used. Hard copy output must accompany all files.
Jeffrey Collins
Phone: 201-748-8864
Fax: 201-748-6825
E-mail: jecollin@wiley.com
Editorial Board
President
L. Loeb
President-Elect
D. Eastmond
|
Secretary
J. Majeska
Treasurer
M. Plewa
| |
C o u n c i l o r s
|
|
M. Aardema
D. Benz
S. Bonassi
L. Cosentino |
J. Essigman
P. Guzzie
P. Hanawalt
M. Hayashi |
K. Hill
D. Kirkland
M. Ljungman
S. Morris |
B. Parsons
J. Sasaki
M. Veigl
| |
|
E D I T O R - I N - C H I E F
Robert H. Heflich
FDA/NCTR
Jefferson, Arkansas
|
|
E D I T O R I A L B O A R D |
Marilyn J. Aardema
Proctor & Gamble Co.
Cincinnati, Ohio
John Ashby
Snygenta Central Toxicology
Laboratory
Cheshire, United Kingdom
William M. Baird
Oregon State University
Environmental & Health Sciences
Corvallis, Oregon
Neil Cariello
Glaxo Wellcome Inc.
Research Triangle Park, North Carolina
Daniel Casciano
NCTR
Jefferson, Arkansas
Thomas A. Cebula
FDA
Washington, DC
Kerry L. Dearfield
U.S. EPA
Washington, DC
David DeMarini
U.S. EPA
Research Triangle Park, North Carolina
Rosalie Elespuru
FDA
Rockville, Maryland
Don G. Ennis
University of Louisiana
Lafayette, Louisiana
James S. Felton
Lawrence Livermore
National Laboratory
Livermore, California
James C. Fuscoe
U.S. FDA/NCTR
Jefferson, Arkansas
Sheila Galloway
Merck Research Laboratories
West Point, Pennsylvania
Larry W. Glickman
University of Victoria
Victoria, British Columbia, Canada
George R. Hoffmann
Holy Cross College
Worcester, Massachusetts
Fred F. Kadlubar
NCTR
Jefferson, Arkansas
Andrew Kligerman
U.S. EPA
Research Triangle Park, North Carolina
Walter Koch
Roche Molecular Systems
Alameda, California
Bernard A. Kunz
Deakin University
Geelong, Victoria, Australia
J. Eugene LeClerc
FDA
Washington, DC
|
Susan Lewis
Research Triangle Institute
Research Triangle Park, North Carolina
Lawrence A. Loeb
University of Washington
Seattle, Washington
Heinrich Malling
NIEHS
Research Triangle Park, North Carolina
William F. Morgan
University of Maryland
Baltimore, Maryland
Alexander Morley
Flinders Medical Centre
Bedford Park, SA, Australia
Takehiko Nohmi
National Institute of Health Sciences
Tokyo, Japan
Peggy L. Olive
BC Cancer Research Centre
Vancouver, British Columbia, Canada
Walter W. Piegorsch
University of South Carolina
Columbia, South Carolina
R. Julian Preston
U.S. EPA (MD-68)
Research Triangle Park, North Carolina
Michael J. Prival
FDA
Washington, DC
Toby G. Rossman
NYU Medical Center
Tuxedo, New York
David W. Sedwick
Case Western Reserve University
Cleveland, Ohio
Michael D. Shelby
NIEHS
Research Triangle Park, North Carolina
Thomas R. Skopek
Merck Research Laboratories
West Point, Pennsylvania
Toshio Sofuni
NovusGene, Inc.
Tokyo, Japan
Peter J. Stambrook
University of Cincinnati College of Medicine
Cincinnati, Ohio
Ray Tice
Integrated Laboratory Systems
Research Triangle Park, North Carolina
Kenneth Tindall
NIEHS
Research Triangle Park, North Carolina
James D. Tucker
Lawrence Livermore National Laboratory
Livermore, California
Andrew J. Wyrobek
Lawrence Livermore National Laboratory
Livermore, California
Errol Zeiger
Errol Zeiger Consulting
Chapel Hill, North Carolina
| |
J o u r n a l P r o d u c t i o n
|
|
John Wiley & Sons
Jeffrey Collins
|
|
